HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT

Clinical trials for HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT explained in plain language.

Never miss a new study

Get alerted when new HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT trials appear

Sign up with your email to follow new studies for HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental cell therapy aims to unlock transplants for Hard-to-Match patients

Disease control Not yet recruiting

This early-phase study is testing a new cell therapy called AZD0120 in adults with end-stage kidney disease who are waiting for a transplant but have high levels of antibodies that make finding a compatible donor very difficult. The goal is to see if this therapy can safely reduc…

Matched conditions: HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT

Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT

Get alerted when new HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT trials appear

Experimental cell therapy aims to unlock transplants for Hard-to-Match patients